Ilaris and Lexiva (Fosamprenavir Tablets)

• Generic Name: canakinumab
• Dosage Forms: injection, powder, lyophilized, for solution
• Other Brand Names: Ilaris

Ilaris (canakinumab) is a monoclonal antibody that blocks certain proteins in the body that can affect inflammation and other immune responses. Ilaris is used to treat certain types of periodic fever syndromes, sometimes called auto-inflammatory syndromes.

Periodic fever syndromes are rare and often inherited conditions caused by mutations in certain genes; usually genes that are involved in producing a certain protein or enzyme in the body. People with a periodic fever syndrome have episodes of fever and inflammation without other causes such as infection or virus.

Ilaris is used to treat the following periodic fever syndromes in adults and children who are at least 4 years old:

• Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Autoinflammatory Syndrome and Muckle-Wells Syndrome
• Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS)
• Hyperimmunoglobulin D Syndrome (HIDS), also called Mevalonate Kinase Deficiency (MKD)
• Familial Mediterranean Fever (FMF)

Ilaris is also used to treat Sudden Juvenile Idiopathic Arthritis (SJIA) in children who are at least 2 years old.

• Generic Name: fosamprenavir
• Dosage Forms: tablet, film coated; oral suspension
• Other Brand Names: Lexiva, Telzir

• It is used to treat HIV infection.